Calcium Pyrophosphate Deposition Disease.
作者信息
Rosenthal Ann K, Ryan Lawrence M
机构信息
From the Division of Rheumatology, Department of Medicine, Medical College of Wisconsin (A.K.R., L.M.R.), and the Department of Medicine, Zablocki Veterans Affairs Medical Center (A.K.R.) - both in Milwaukee.
出版信息
N Engl J Med. 2016 Jun 30;374(26):2575-84. doi: 10.1056/NEJMra1511117.
Abstract
摘要
相似文献
1
Calcium Pyrophosphate Deposition Disease.
N Engl J Med. 2016 Jun 30;374(26):2575-84. doi: 10.1056/NEJMra1511117.
2
Crystal arthritis: calcium pyrophosphate deposition-nothing 'pseudo' about it!
Nat Rev Rheumatol. 2011 May;7(5):257-8. doi: 10.1038/nrrheum.2011.50.
3
Treating difficult crystal pyrophosphate dihydrate deposition disease.
Curr Rheumatol Rep. 2008 Jul;10(3):228-34. doi: 10.1007/s11926-008-0037-2.
4
[Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].
Z Rheumatol. 2007 Nov;66(7):573-4, 576-8. doi: 10.1007/s00393-007-0221-1.
5
Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?
Arthritis Res Ther. 2015 Apr 1;17(1):89. doi: 10.1186/s13075-015-0598-1.
6
Imaging characteristics of calcium pyrophosphate dihydrate crystal deposition disease.
Am J Phys Med Rehabil. 2014 Mar;93(3):272-3. doi: 10.1097/PHM.0b013e31825566aa.
7
Calcium pyrophosphate crystals detected by ultrasound in patients without radiographic evidence of cartilage calcifications.
J Rheumatol. 2010 Dec;37(12):2602-3. doi: 10.3899/jrheum.100653.
8
Calcium pyrophosphate dihydrate crystal deposition disease: nomenclature and diagnostic criteria.
Ann Intern Med. 1977 Aug;87(2):241-2. doi: 10.7326/0003-4819-87-2-240.
9
Evaluating CPPD crystal deposition, an important disease of aging.
Geriatrics. 1988 Nov;43(11):59-64, 68.
10
Crystal arthritis: contemporary approaches to diseases of antiquity.
Clin Med (Lond). 2007 Jan-Feb;7(1):60-4. doi: 10.7861/clinmedicine.7-1-60.
引用本文的文献
1
A Fragile Phosphate/Pyrophosphate Balance: From Essential Mineralization to Rare Calcifying Diseases.
Curr Osteoporos Rep. 2025 Aug 6;23(1):34. doi: 10.1007/s11914-025-00928-z.
2
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for calcium pyrophosphate deposition disease.
Clin Rheumatol. 2025 Aug 6. doi: 10.1007/s10067-025-07596-5.
3
Chondrocalcinosis and incident knee osteoarthritis: findings from 2 large prospective cohorts with 20 years of follow-up.
Ann Rheum Dis. 2025 Aug 4. doi: 10.1016/j.ard.2025.07.009.
4
Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval.
Adv Ther. 2025 Jul 25. doi: 10.1007/s12325-025-03309-1.
5
Ultrasonographic Assessment of Calcium Pyrophosphate Deposition Disease: A Comprehensive Review.
J Pers Med. 2025 Jul 1;15(7):280. doi: 10.3390/jpm15070280.
6
Phosphate in Physiological and Pathological Mineralization: Important yet Often Unheeded.
MedComm (2020). 2025 Jul 13;6(7):e70298. doi: 10.1002/mco2.70298. eCollection 2025 Jul.
7
Pseudogout-Induced Cervical Myelopathy: A Report of Two Cases and Review of the Literature.
Cureus. 2025 May 31;17(5):e85145. doi: 10.7759/cureus.85145. eCollection 2025 May.
8
Steroid or pseudogout? Analysis of white deposits in tissues during surgery.
Arch Orthop Trauma Surg. 2025 Jun 16;145(1):345. doi: 10.1007/s00402-025-05945-2.
9
The coexistence of crowned dens sign and calcification of ligamentum flavum in the cervical spine: mere coincidence or meaningful association?
Medicine (Baltimore). 2025 Jun 6;104(23):e42630. doi: 10.1097/MD.0000000000042630.
10
Lumbar Intraspinal Calcium Pyrophosphate Deposition: A Comprehensive Case Study.
J Cent Nerv Syst Dis. 2025 Jun 6;17:11795735251347335. doi: 10.1177/11795735251347335. eCollection 2025.
本文引用的文献
1
Comparison of outcomes after UKA in patients with and without chondrocalcinosis: a matched cohort study.
Knee Surg Sports Traumatol Arthrosc. 2017 Jan;25(1):319-324. doi: 10.1007/s00167-015-3578-8. Epub 2015 Mar 19.
2
Imaging of calcium pyrophosphate deposition disease.
Curr Rheumatol Rep. 2015 Mar;17(3):20. doi: 10.1007/s11926-015-0496-1.
3
Pseudogout at the knee joint will frequently occur after hip fracture and lead to the knee pain in the early postoperative period.
J Orthop Surg Res. 2015 Jan 14;10:4. doi: 10.1186/s13018-014-0145-9.
4
Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides.
J Rheumatol. 2015 Mar;42(3):513-20. doi: 10.3899/jrheum.140634. Epub 2014 Nov 15.
5
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.
Arthritis Res Ther. 2014 Oct 15;16(5):458. doi: 10.1186/s13075-014-0458-4.
6
A gain of function mutation in TNFRSF11B encoding osteoprotegerin causes osteoarthritis with chondrocalcinosis.
Ann Rheum Dis. 2015 Sep;74(9):1756-62. doi: 10.1136/annrheumdis-2013-205149. Epub 2014 Apr 17.
7
The progressive ankylosis gene product ANK regulates extracellular ATP levels in primary articular chondrocytes.
Arthritis Res Ther. 2013 Oct 17;15(5):R154. doi: 10.1186/ar4337.
8
Association between low cortical bone mineral density, soft-tissue calcification, vascular calcification and chondrocalcinosis: a case-control study.
Ann Rheum Dis. 2014 Nov;73(11):1997-2002. doi: 10.1136/annrheumdis-2013-203400. Epub 2013 Aug 2.
9
Eighteen cases of crowned dens syndrome: Presentation and diagnosis.
Neurochirurgie. 2013 Jun;59(3):115-20. doi: 10.1016/j.neuchi.2013.03.003. Epub 2013 Jun 24.
10
Pseudogout-associated inflammatory calcium pyrophosphate dihydrate microcrystals induce formation of neutrophil extracellular traps.
J Immunol. 2013 Jun 15;190(12):6488-500. doi: 10.4049/jimmunol.1203215. Epub 2013 May 15.
Zotero 插件